CHRNA4 and nicotine dependence: Selective α6β2-nAChR antagonist (222). Nicotine-evoked dopamine activation and nicotine reinforcement are mediated by α6β2-nAChRs expressed by dopaminergic neurons. bPiDI blocks nicotine’s effects on these receptors, making them therapeutic targets for nicotine addiction (223).